Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43,056,667
-
Total 13F shares
-
27,272,759
-
Share change
-
-479,165
-
Total reported value
-
$47,994,480
-
Price per share
-
$1.76
-
Number of holders
-
44
-
Value change
-
-$585,720
-
Number of buys
-
10
-
Number of sells
-
15
Institutional Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q3 2025
As of 30 Sep 2025,
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,272,759 shares.
The largest 10 holders included
BVF INC/IL, Blue Owl Capital Holdings LP, ORBIMED ADVISORS LLC, Versant Venture Management, LLC, Redmile Group, LLC, MPM ASSET MANAGEMENT LLC, MPM BIOIMPACT LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, and Rangeley Capital, LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.